Navigation Links
Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary Endpoint in a Study of Adult Subjects With a History of Grass Pollen Allergies
Date:11/2/2009

KENILWORTH, N.J., Nov. 2 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced that its investigational sublingual Grass (Phleum Pratense) Allergy Immunotherapy Tablet (AIT) has met the primary endpoint in a Phase III study of adult subjects in the U.S. with a history of grass pollen induced rhinoconjunctivitis with or without asthma. The investigational Grass AIT treatment is designed to work by inducing a protective immune response against grass pollen allergy and providing sustained prevention of allergy symptoms, treating both the symptoms and the underlying cause of the disease.

The study was a U.S. multicenter, randomized, placebo-controlled, double-blind, parallel-group clinical trial evaluating the efficacy of the grass sublingual tablet versus placebo in the treatment of grass pollen-induced rhinoconjunctivitis based on the combined (sum of) rhinoconjunctivitis daily symptom score (DSS) and rhinoconjunctivitis daily medication score (DMS) averaged over the entire grass pollen season (GPS). In the study 439 adults were randomized to receive either placebo or grass tablet. The study met its primary endpoint. Additionally, the adverse events experienced by subjects receiving the drug in this study were similar to previous studies in adults and include oral itching, with no new or unexpected findings.

These data are planned to be submitted for presentation at a U.S. medical conference in 2010.

SCHERING-PLOUGH DISCLOSURE NOTICE: The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the plans for, the potential of and the potential market for asenapine. Forward-looking statements relate to expectations or forecasts of future events. Scheri
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
2. A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
3. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
4. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
5. Replidynes Investigational Antibacterial Agent REP3123 Prevents Sporulation in Clostridium difficile
6. Replidynes Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile
7. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
8. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
9. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
10. Lexicon Reports Initial Clinical Trial Results for LX1031, an Investigational New Drug for Irritable Bowel Syndrome
11. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... Smith & Nephew ( SN...nounce the signing of a technology development con... that may lead to the creation of a fracture fixat... of the limbs of soldiers who sustain battlefield ...search Projects Agency (DARPA), the central resear...
(Date:11/19/2009)... 19 BioCryst Pharmaceuti...icing of a public offering of 5,000,000 shares of ...gross proceeds of $48.75 million. All of the shar...fective shelf registration statement previously fi...BioCryst has also granted the underwriters a 30-da...
(Date:11/19/2009)...v. 19 /PRNewswire-Asia/ -- ScinoPharm, a leading g...s (APIs), announced that its,Tainan facility has r...rom,SafeBridge(R) Consultants, Inc. The Certificat...cy in the safe handling of potent active,pharmaceu...laboratories and,production areas used for the man...
Breaking Medicine Technology:Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3ScinoPharm Announces SafeBridge Potent Compound Safety Certification 213 Year Old Seeking to 26amp 3B 238220 3BE Travel 26amp 3B 238221 3B The World to Raise Awareness for Juvenile Diabetes 61236 113 Year Old Seeking to 26amp 3B 238220 3BE Travel 26amp 3B 238221 3B The World to Raise Awareness for Juvenile Diabetes 61236 2In Time for World Diabetes Day November 14 2009 New Website Empowers Diabetes Patients to Learn and Earn 61234 1In Time for World Diabetes Day November 14 2009 New Website Empowers Diabetes Patients to Learn and Earn 61234 2Senior Quality Lifestyles Corporation Announces Completion of 24164 855 000 in Financing for The Stayton at Museum Way 61232 1Senior Quality Lifestyles Corporation Announces Completion of 24164 855 000 in Financing for The Stayton at Museum Way 61232 2Senior Quality Lifestyles Corporation Announces Completion of 24164 855 000 in Financing for The Stayton at Museum Way 61232 3
(Date:11/22/2009)..., , WASHINGTON, Nov. 21 /PRNewswire-USNewswir...ollowing statement upon the United States Senate,s...ealth Care legislation: ,, "Senators Arlen Spec...ians and all Pennsylvanians for casting stand-up, ...sident Obama,s historic Affordable Health Care Ref...
(Date:11/21/2009)..., , WASHINGTON, Nov. 21 /PRNewswire-USNews...0s to eliminate onchocerciasis (river blindness) i...lence of the disease in recent years, as evidenced...quiring mass drug administration in six endemic co...annual meeting of the American Society of Tropical...
(Date:11/21/2009)... HAPPYneuron,s most popula... on the iPhone and iPod Touch. , ...9 -- HAPPYneuron,s most popular and addictive game...Pod Touch. Split Words is designed to help banish ...e SplitWords iPhone brain game challenges the br...
(Date:11/20/2009)..., , PRINCETON, NJ, Nov. 20 /PRNewswire-Firs...oday that a Special Meeting of Shareholders will b...f the Meeting is to consider approval of two speci... approve and authorize the sale of all or substant...on the terms provided for in the asset purchase ag...
(Date:11/20/2009)..., , MADISON, N.J., Nov. 20 /PRNewswire-Fi...fluenza virus may have peaked in late October, but...l source of illness in all age groups, including t...gnostics Incorporated (NYSE: DGX ), the world,s ...n and services. ,, In its most recent Quest Di...
Breaking Medicine News(10 mins):Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3
...lantable materials that grab stem cells and spur t...g surgeries. Linda Griffith and her colleagues// a...al that could help cells survive the harsh transpl...s. "Creating instructional biomaterials li...
...our-decade long study has come out in support of t...r health. Dutch researchers examined around 1500 m...rs. They have concluded that while drinking les...inked with the lowest rates of deaths. Wine drinke...
...ueensland Health communiqué released yesterday has...ckay. The report has brought to the fore lacunae//...ed heart attacks or hip replacements at Mackay Bas...ompared to other hospitals in the state. A hospi...
...ew survey confirms that pulmonary/critical care ph...ues and are actively managing their patient's slee...ollege of Chest Physicians Sleep Institute (ACCP-S...e therapies to manage their patient's sleep proble...
...YON -- Wet sorghum distiller's grains can be fed i...iciencies, said two researchers//. The two fo...g heifers were conducted by Dr. Mike Brown, a Texa...ulture-Agricultural Research Service animal scient...
...the FDA cannot approve an abbreviated new drug app...thdrawn due to reasons of safety or efficacy// , t...hdrawal before approving any generic version. ...gulatory requirements are met. The FDA added that ...
Other Medicine News:Health News:Healing Bone With Stem Cells 2Health News:Doctors Not Drowsy When Treating Women's Sleep Issues 2Health News:Doctors Not Drowsy When Treating Women's Sleep Issues 3Health News:Wet Distiller's Grains Could Play a Role in Cattle Diets 2Health News:Wet Distiller's Grains Could Play a Role in Cattle Diets 3
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
Medicine Products: